Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model-Reference-Cited by-同舟云学术

Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model

Published:2024-06 Issue: Volume:199 Page:114300
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Kuryk Lukasz^ORCID,Mathlouthi Sara,Wieczorek Magdalena^ORCID,Gad Beata^ORCID,Rinner Beate,Malfanti Alessio^ORCID,Mastrotto Francesca^ORCID,Salmaso Stefano^ORCID,Caliceti Paolo^ORCID,Garofalo Mariangela^ORCID

Funder

National Science Centre Poland

European Commission

University of Padua

National Centre for Research and Development

Publisher

Elsevier BV

Reference64 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Current and future burden of breast cancer: global statistics for 2020 and 2040;Arnold;Breast,2022

3. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

4. Molecular portraits of human breast tumours;Perou;Nature,2000

5. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin. Cancer Res.,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arrest and Attack: Microtubule-Targeting Agents and Oncolytic Viruses Employ Complementary Mechanisms to Enhance Anti-Tumor Therapy Efficacy;Genes;2024-09-11

2. Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments;Cancer Cell International;2024-07-11